AMINA BALOCH: Open Payments
NPI 1336698901 · OAKBROOK TERRACE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$729 in 31 payments from 11 companies in 2025. Trend: 2023 $447 · 2024 $626 · 2025 $729
Food & beverage: $729
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $322 |
| Neurocrine BioSciences, Inc. | 4 | $123 |
| Teva Pharmaceuticals USA, Inc. | 3 | $56 |
| Phathom Pharmaceuticals, Inc. | 2 | $52 |
| Lundbeck LLC | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| JAZZ PHARMACEUTICALS INC. | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
Products named: CAPLYTA, INGREZZA, REXULTI, VOQUEZNA, AUSTEDO XR, EPIDIOLEX, GEMTESA, VRAYLAR.
Industry payments across IL — which companies pay providers there.
